Latest publications for June 2023 from Cochrane Infectious Diseases Group
During June 2023, the CIDG published two new Cochrane Protocols in Issue 6, 2023 of the Cochrane Database of Systematic Reviews.
New Cochrane Protocols
- Gloeck NR, Leong T, Iwu-Jaja CJ, Katoto Pd, Kredo T, Wiysonge CS. Typhoid conjugate vaccines for preventing typhoid fever (enteric fever). Cochrane Database of Systematic Reviews 2023, Issue 6. Art. No.: CD015746. DOI: 10.1002/14651858.CD015746.
- Vilyte G, Fox T, Rohwer AC, Volmink J, McCaul M. Digital devices for tuberculosis treatment adherence. Cochrane Database of Systematic Reviews 2023, Issue 6. Art. No.: CD015709. DOI: 10.1002/14651858.CD015709.
Other news
In April 2023, Tilly Fox (CIDG Review Synthesis Delivery Specialist) attended a 3-day Network Meta-Analysis workshop in Ireland, hosted by Evidence Synthesis Ireland. You can read about it here.
Also, Dr Rebecca Kuehn (CIDG Clinical Research Associate) attended the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Copenhagen, Denmark. You can read her travel report from the conference here
Cochrane 2022 Journal Impact Factor
The Cochrane Database of Systematic Reviews (CDSR) Journal Impact Factor is 8.4. This is a change from the 2021 Journal Impact Factor (JIF), which was 11.874.
The CDSR JIF is calculated by taking the total number of citations in a given year (2022) to all Cochrane Reviews published in the past 2 years (2021 and 2020) and dividing that number by the total number of Reviews published in the past 2 years (2021 and 2020). While JIF is a useful measure of average citation frequency, it is not the only measure of success or impact. As in previous years, Wiley will be compiling the main Impact Report as well as the individual Review Group reports and datapacks (for all active CRGs). The reports are due to be circulated in August 2023.
In the meantime, some take-aways of the CDSR 2022 JIF include:
- The CDSR is ranked 22nd of the 167 journals in the Medicine, General & Internal category (in the 87th percentile)
- The CDSR received 83,897 cites in the 2022 JIF period, compared with 92,845 in 2021 (continuing to remain in the top 5 in the CDSR’s JCR category)
- The 5-Year JIF is 10.9 compared with 11.956 in 2021
Throughout 2023, we will continue to add publications to our CIDG and READ-It websites regularly. Do check our websites for regular updates and follow us on Twitter.
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.